Yesterday Abbott (NYSE: ABT) reported fourth quarter and full year results and of course the FreeStyle Libre continues to exceed expectations. The company noted they are adding 50,000 patients per quarter which as we noted yesterday is an accomplishment as they have just begun selling the Libre in the US and Canada. The company also noted they would be investing heavily in Libre coming out with updated versions in the future.
What didn’t happen yesterday was Dexcom (NASDAQ: DXCM) getting crushed. Shares closed up for the day and continue to show gains today. This is in stark contrast . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.